Page last updated: 2024-10-26

dipyridamole and Mumps

dipyridamole has been researched along with Mumps in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Mumps: An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujieda, M1
Kinoshita, A1
Naruse, K1
Nakayama, T1
Moriki, T1
Wakiguchi, H1
Kurashige, T1

Other Studies

1 other study available for dipyridamole and Mumps

ArticleYear
Mumps associated with immunoglobulin A nephropathy.
    The Pediatric infectious disease journal, 2000, Volume: 19, Issue:7

    Topics: Antibodies, Viral; Biopsy; Child, Preschool; Dipyridamole; Enzyme-Linked Immunosorbent Assay; Glomer

2000